MR-proANP and NT-proBNP were compared head-to-head for heart failure diagnosis in emergency settings, with both showing excellent diagnostic performance — MR-proANP as a validated alternative.
Key findingMR-proANP and NT-proBNP were compared head-to-head for heart failure diagnosis in emergency settings, with both showing excellent diagnostic performan
What the researchers found
MR-proANP and NT-proBNP were compared head-to-head for heart failure diagnosis in emergency settings, with both showing excellent diagnostic performance — MR-proANP as a validated alternative.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
Journal of internal medicine, 267(1), 119-29
Citation
Potocki, M; Breidthardt, T; Reichlin, T; Hartwiger, S; Morgenthaler, N G; Bergmann, A; Noveanu, M; Freidank, H; Taegtmeyer, A B; Wetzel, K; Boldanova, T; Stelzig, C; Bingisser, R; Christ, M; Mueller, C. (2010). Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.. Journal of internal medicine, 267(1), 119-29. https://doi.org/10.1111/j.1365-2796.2009.02135.x